Ulla Lepola

Psychology · Social Sciences

30h-index3.2kcitations115works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes(47), Treatment of Major Depression(31), Mental Health Research Topics(24), Child and Adolescent Psychosocial and Emotional Development(22), Epilepsy research and treatment(11)

Publications115 total

Obsessive Compulsive Disorder (OCD)
2024
Adjunctive brexpiprazole for elderly patients with major depressive disorder: An open‐label, long‐term safety and tolerability study
International Journal of Geriatric Psychiatry·2018· 14 citedOpen Access
Pakko-oireinen häiriö
2017
Efficacy and tolerability of flexibly-dosed adjunct TC-5214 (dexmecamylamine) in patients with major depressive disorder and inadequate response to prior antidepressant
European Neuropsychopharmacology·2013· 42 cited
Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial
Depression and Anxiety·2010· 82 cited
Postoperative psychoses in epileptic patients after temporal lobectomy
Acta Neurologica Scandinavica·2009· 59 cited
Efficacy, safety, and tolerability of fixed-dose desvenlafaxine 50 and 100 mg/day for major depressive disorder in a placebo-controlled trial
International Clinical Psychopharmacology·2008· 123 cited
P.2.g.008 Extended release quetiapine fumarate monotherapy as maintenance treatment in patients with major depressive disorder (MDD)
European Neuropsychopharmacology·2008· 4 cited
Substituting Carbamazepine with Oxcarbazepine Increases Citalopram Levels. A Report on Two Cases
Pharmacopsychiatry·2007· 38 cited
Psychiatry
2006
A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder
Depression and Anxiety·2006· 103 citedOpen Access
Escitalopram of its Use in the Management of Anxiety Disorders
2006
Deramciclane in the treatment of generalized anxiety disorder: A placebo-controlled, double-blind, dose-finding study
European Neuropsychopharmacology·2005· 17 cited
Psychiatric drug trials and placebo
Nordic Journal of Psychiatry·2005· 5 cited
Efficacy of Venlafaxine ER in patients with social anxiety disorder: a double‐blind, placebo‐controlled, parallel‐group comparison with paroxetine
Human Psychopharmacology Clinical and Experimental·2004· 110 cited
Do equivalent doses of escitalopram and citalopram have similar efficacy? A pooled analysis of two positive placebo-controlled studies in major depressive disorder
International Clinical Psychopharmacology·2004· 93 cited
Controlled-Release Paroxetine in the Treatment of Patients With Social Anxiety Disorder
The Journal of Clinical Psychiatry·2004· 66 cited
Placebo i psykiatriska läkemedelsprövningar ; översättning: Matts Forsskåhl
STM:n Hallinnonalan avoin julkaisuarkisto (Julkari)·2004Open Access
Lume psykiatrisissa lääketutkimuksissa
STM:n Hallinnonalan avoin julkaisuarkisto (Julkari)·2004Open Access
The placebo in psychiatric drug trials
STM:n Hallinnonalan avoin julkaisuarkisto (Julkari)·2004Open Access
page 1 of 6Next →

Frequent Co-authors

Hannu Koponen(25), Esa Leìnonen(18), Paavo Riekkinen(7), Ranan Rimón(6), Alan Wade(4), Jyrki T. Kuikka(3), Kim Bergström(3), Riitta Jokinen(3), Gérard Emilien(3), J. Turtonen(3), P. Riekkinen(3), Jukka Jolkkonen(3), Jari Tiihonen(2), Henrik Loft(2), Elin Heldbo Reines(2), Pauli Vainio(2), Ingemar Sjödin(2), Jukka Penttinen(2), Heikki Lehto(2), Asla Pitkänen(2)